We at Gene Signal are committed to vigorously researching and developing new therapeutic solutions to conquer angiogenesis/angiostatic-based diseases associated with significant unmet medical needs despite the advent of VEGF (Vascular Endothelial Growth Factor) based therapies.

We seek to build a momentum of constant innovation and work hard to deliver the highest quality therapies to patients and their families.  We support and work hand in hand with the research and medical communities, and are passionate about what we do.

The Gene Signal team is dedicated to building value for its share holders: the management team as part owners of the business are devoted to building sustainable long-term success.

We are ethically minded and support open and honest communication. Driven by science and business, we are committed to team work, and believe in the value of diversity of experiences.